1. Home
  2. OCS vs MVST Comparison

OCS vs MVST Comparison

Compare OCS & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • MVST
  • Stock Information
  • Founded
  • OCS 2003
  • MVST 2006
  • Country
  • OCS Switzerland
  • MVST United States
  • Employees
  • OCS N/A
  • MVST N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • MVST Industrial Machinery/Components
  • Sector
  • OCS Health Care
  • MVST Miscellaneous
  • Exchange
  • OCS Nasdaq
  • MVST Nasdaq
  • Market Cap
  • OCS 689.8M
  • MVST 680.5M
  • IPO Year
  • OCS N/A
  • MVST N/A
  • Fundamental
  • Price
  • OCS $19.45
  • MVST $3.59
  • Analyst Decision
  • OCS Strong Buy
  • MVST Strong Buy
  • Analyst Count
  • OCS 4
  • MVST 1
  • Target Price
  • OCS $31.50
  • MVST $3.00
  • AVG Volume (30 Days)
  • OCS 29.0K
  • MVST 11.6M
  • Earning Date
  • OCS 05-08-2025
  • MVST 05-12-2025
  • Dividend Yield
  • OCS N/A
  • MVST N/A
  • EPS Growth
  • OCS N/A
  • MVST N/A
  • EPS
  • OCS N/A
  • MVST N/A
  • Revenue
  • OCS $847,333.00
  • MVST $414,941,000.00
  • Revenue This Year
  • OCS $53.79
  • MVST $25.99
  • Revenue Next Year
  • OCS $1,860.95
  • MVST $29.81
  • P/E Ratio
  • OCS N/A
  • MVST N/A
  • Revenue Growth
  • OCS N/A
  • MVST 21.68
  • 52 Week Low
  • OCS $10.79
  • MVST $0.15
  • 52 Week High
  • OCS $23.08
  • MVST $4.32
  • Technical
  • Relative Strength Index (RSI)
  • OCS 58.76
  • MVST 64.31
  • Support Level
  • OCS $17.33
  • MVST $3.74
  • Resistance Level
  • OCS $20.45
  • MVST $4.32
  • Average True Range (ATR)
  • OCS 0.80
  • MVST 0.44
  • MACD
  • OCS 0.19
  • MVST 0.03
  • Stochastic Oscillator
  • OCS 68.75
  • MVST 65.57

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About MVST Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.

Share on Social Networks: